US2003073975A1PendingUtilityA1
Lipid pool aspiration arrangement for the treatment of vulnerable atherosclerosis plaque
Priority: Feb 10, 2000Filed: Jul 16, 2002Published: Apr 17, 2003
Est. expiryFeb 10, 2020(expired)· nominal 20-yr term from priority
A61B 2017/22081A61B 2017/22082A61B 17/3478
42
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention comprises a vulnerable plaque treatment catheter arrangement for the treatment of a lipid pool at a site of vulnerable plaque within an artery. The catheter arrangement includes an elongated, hollow, flexible shaft having a proximal end and a distal end and an elongated, flexible, steerable, lipid-enterable needle arranged within the shaft. The needle has at least one lumen therethrough in communication with a treatment source, to permit the rendering of the lipid pool into an innocuous entity.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A vulnerable plaque treatment catheter arrangement for the treatment of a lipid pool at a site of vulnerable plaque within an artery, said catheter arrangement comprising:
an elongated, hollow, flexible shaft having a proximal end and a distal end; an elongated, flexible, lipid-enterable needle arranged within said shaft, said needle having at least one lumen therethrough in communication with a treatment source, to permit the rendering of said lipid pool into an innocuous entity.
2 . The vulnerable plaque treatment catheter arrangement as recited in claim 1 , wherein said needle is rotatable within said hollow shaft, to permit said catheter to be steered.
3 . The vulnerable plaque treatment catheter arrangement as recited in claim 1 , wherein said lumen in said needle is connected to a vacuum source to permit said lipid pool to be suctioned through said needle by said vacuum source.
4 . The vulnerable plaque treatment catheter arrangement as recited in claim 1 , wherein said lumen in said needle is connected to a pressurized fluid source to permit said lipid pool to be treated by a liquid or gas medicament.
5 . The vulnerable plaque treatment catheter arrangement as recited in claim 1 , wherein said lumen in said needle is connected to an optical viewing apparatus by an optical fiber to permit said lipid pool to be monitored by an attendant.
6 . The vulnerable plaque treatment catheter arrangement as recited in claim 1 , wherein said needle has a plurality of lumens therethrough, each in communication with a fluid pressure source and a suction source respectively to permit a lipid pool to be suctioned and medicated thereby
7 . The vulnerable plaque treatment catheter arrangement as recited in claim 6 , wherein said sheath has a position indicator band arranged adjacent its distal end to permit locating of said needle relative to a lipid pool.
8 . A method of treating a vulnerable plaque in a coronary artery by the use of a vulnerable plaque treatment catheter arrangement comprising the steps of:
arranging a movable hollow needle in an elongated flexible catheter sheath; extending a lumen through said needle, from a distal tip thereof, to a treatment source proximal of said catheter sheath; pushing said catheter into an artery to be treated, so said distal end of said needle reaches a lipid pool in said artery; piercing a fibrous cap of said lipid pool by said tip of said needle; and actuating said treatment source to as to effect treatment of said lipid pool by said catheter arrangement.
9 . The method as recited in claim 8 , including the step of:
providing a vacuum at said treatment source so as to provide a suction at said distal tip of said needle in said lipid pool to draw said lipid therefrom.
10 . The method as recited in claim 8 , including the step of:
providing a fluid pressure at said treatment source so as to provide a fluid to be introduced into said lipid pool in said artery.
11 . The method as recited in claim 8 , including the step of:
arranging an optical fiber through said lumen so as to permit said lipid pool to be monitored visually.
12 . The method as recited in claim 8 , including the step of:
steering said catheter sheath into said artery by articulation of said needle with respect to said sheath.
13 . The method as recited in claim 8 , including the steps of:
suctioning said lipid pool by a vacuum source at said proximal end of said lumen; and introducing a treatment fluid into said lipid pool from a pressurized treatment fluid source through a second lumen extending through said needle.
14 . The method as recited in claim 13 , including the step of:
viewing said lipid pool through an optical fiber arranged through a third lumen in said needle, said fiber having a proximal end in communication with a viewing monitor.
15 . The method as recited in claim 10 , wherein said fluid introduced into said lipid pool renders said lipid pool inert.
16 . The method as recited in claim 10 , wherein said fluid introduced into said lipid pool renders said lipid pool into a non-thrombogenic semi-solid material.Join the waitlist — get patent alerts
Track US2003073975A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.